By December 31, 2009 (nine, not eight), the Seattle Merck “lab” is closing. But Rosetta Biosoftware isn’t technically the lab, so there are other plans in the work for Rosetta Biosoftware and GEL Operations. We don’t know all the details yet, so that kinda sucks, but i’m not too worried about it right now.
Its kinda sad: in a ~3500 word press release about Merck’s 3Q2008 earnings, its single a whopping sentence:
This will provide a more efficient use of research facilities and result in the closure of three basic research sites in Tsukuba, Japan; Pomezia, Italy; and Seattle by the end of 2009.
33 words. 0.94%. Not statistically significant, as the statistics people would say.
More news as I know more!
ETA: The new official statement:
Today Merck & Co. announced its intent to close its Seattle research site. At Rosetta Biosoftware, however, we are continuing with business as usual. Rosetta Biosoftware continues to operate as a commercial provider of life science software solutions. Rosetta Biosoftware is a separate business unit of Rosetta Inpharmatics LLC, wholly owned subsidiary of Merck.
Leave a Reply